Iota-Carrageenan Inhibits Replication of the SARS-CoV-2 Variants of Concern Omicron BA.1, BA.2 and BA.5
Even with its endemic transition, the COVID-19 pandemic remains a public health threat, particularly in the light of emerging variants of concern (VoCs) and the need for pandemic preparedness in the future. In November 2021, the SARS-CoV-2 VoC Omicron emerged and its subvariants BA.1, BA.2 and BA.5...
Main Authors: | Christian Setz, Maximilian Große, Maria Fröba, Janina Auth, Pia Rauch, Alexandra Herrmann, Arne Cordsmeier, Armin Ensser, Michael Schindler, Martina Morokutti-Kurz, Philipp Graf, Benedikt Engel, Eva Prieschl-Grassauer, Andreas Grassauer, Ulrich Schubert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Nutraceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1661-3821/3/3/25 |
Similar Items
-
Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta
by: Maria Fröba, et al.
Published: (2021-12-01) -
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
by: Martina Morokutti-Kurz, et al.
Published: (2021-01-01) -
Iota-Carrageenan is a potent inhibitor of rhinovirus infection
by: Meier Christiane, et al.
Published: (2008-09-01) -
Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat
by: Morokutti-Kurz M, et al.
Published: (2017-02-01) -
Non-clinical safety evaluation of intranasal iota-carrageenan.
by: Alexandra Hebar, et al.
Published: (2015-01-01)